# Diagnostic Assessment of Amino Acid PET/MRI in the Evaluation of Glioma and Brain Metastases

> **NCT04111588** · — · RECRUITING · sponsor: **Norwegian University of Science and Technology** · enrollment: 160 (estimated)

## Conditions studied

- Brain Neoplasms

## Interventions

- **OTHER:** Diagnostic Amino acid PET/MRI examination

## Key facts

- **NCT ID:** NCT04111588
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-11-25
- **Primary completion:** 2025-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-06-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04111588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04111588, "Diagnostic Assessment of Amino Acid PET/MRI in the Evaluation of Glioma and Brain Metastases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04111588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*